Cancer-associated antigen
AssigneeViventia Bio Inc.
InventorsFrancina C. Chahal, Glen MacDonald, Jeannick Cizeau
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
Claims11
An isolated antibody or an antibody fragment that binds to an epitope on SEQ ID NO:
- 2.
An immunoconjugate comprising an antibody or an antibody fragment that binds to an epitope on SEQ ID NO:
- 2, and is attached to an effector molecule.
A kit for diagnosing cancer comprising an isolated antibody or an antibody fragment that binds to an epitope on SEQ ID NO:
- 2 and instructions for the use thereof to diagnose cancer.
Dependencies are inferred from the claim text.